Pancreatic Cancer Research

ResearcherMedical University of SilesiaActive in the last 2 years

Sławomir Mrowiec

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2206-3144; OpenAlex author ID A5029054576. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 11

  1. Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19-9 undergoing pancreatic ductal adenocarcinoma resection. Last author DOI 10.1080/14737140.2026.2699780↗
  2. Post-Pancreatectomy Acute Pancreatitis in Pancreatic Cancer: A Single-Center Experience. Last author DOI 10.3390/medicina62091788↗
  3. Impact of Vitamin D Status on Pancreatic Cancer Risk and Outcomes. First author DOI 10.3390/nu18050837↗
  4. The realities of oncological surveillance after surgery for pancreatic adenocarcinoma in Poland and worldwide - a narrative review. Last author DOI 10.5604/01.3001.0055.6328↗
  5. Pancreatic Cancer and Benign Pancreatic Cystic Lesions: Differences in Cytokines, Growth Factors, and Immunological Markers Concentrations in Serum and Cystic … Co-author DOI 10.3390/cancers17172783↗
  6. Complete Pathological Response to Neoadjuvant Treatment in Pancreatic Ductal Adenocarcinoma-Can We Achieve a Long-Term Survival? A Narrative Review. Last author DOI 10.3390/life15121833↗
  7. Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma - a prospective s… Co-author DOI 10.5114/wo.2024.137760↗
  8. Vascular Resection in Pancreatectomy-Is It Safe and Useful for Patients with Advanced Pancreatic Cancer? Last author DOI 10.3390/cancers14051193↗
  9. Associations between Nutritional and Immune Status and Clinicopathologic Factors in Patients with Pancreatic Cancer: A Comprehensive Analysis. Last author DOI 10.3390/cancers13205041↗
  10. The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, an… Last author DOI 10.26402/jpp.2020.5.09↗
  11. Precursor lesions of early onset pancreatic cancer. Co-author DOI 10.1007/s00428-011-1056-3↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ewa Grudzińska · 5 shared papers, 2025–2026 · strength 1.98
  2. Magdalena Gajda · 4 shared papers, 2025–2026 · strength 1.65
  3. Beata Jabłońska · 3 shared papers, 2021–2026 · strength 1.11
  4. Łukasz Liszka · 2 shared papers, 2011–2025 · strength 0.36
  5. Zenon Paweł Czuba · 1 shared paper, 2025 · strength 0.33
  6. Paweł Lampe · 2 shared papers, 2011–2024 · strength 0.25
  7. Sergiusz Nawrocki · 1 shared paper, 2024 · strength 0.22
  8. Michał Piątek · 1 shared paper, 2024 · strength 0.22
  9. Andrzej Lekstan · 1 shared paper, 2020 · strength 0.13
  10. Daria Dranka-Bojarowska · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.